This study is currently not recruiting participants.
A Prospective Multicenter Trial to Assess the Safety and Effectiveness of the SYNERGYTM Everolimus-Eluting Platinum Chromium Coronary Stent System (SYNERGYTM Stent System) for the Treatment of Atherosclerotic Lesion(s)
Not Recruiting
18 years - 100 years
All
Phase
N/A
Brief description of study.
The EVOLVE II study is being done to compare the safety and usefulness of two drug-eluting stents in the treatment of coronary artery disease.
Detailed description of study
The EVOLVE II study is being done to compare the safety and usefulness of two drug-eluting stents in the treatment of coronary artery disease.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
Conditions:Coronary Artery Disease
Age:
18 years - 100 years
Gender: All
Updated on
19 Jun 2013.
Study ID: 1304011280
Interested in the study?
Select a study center that’s convenient for you, and get in touch with the study team.
